Chemoprevention of head and neck cancer by green tea extract: EGCG-the role of EGFR signaling and "lipid raft"

Journal of Oncology

Volumn , Issue , 2011, Pages

  Masuda, Muneyuki ^a   Wakasaki, Takahiro ^b   Toh, Satoshi ^b   Shimizu, Masahito ^c   Adachi, Seiji ^c  

^a KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT;

CARCINOGENESIS; CHEMOPROPHYLAXIS; DRUG ACTIVATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HEAD AND NECK CARCINOMA; HUMAN; LIPID RAFT; MOLECULARLY TARGETED THERAPY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 79952240835     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/540148     Document Type: Review

References (49)

1. Hunter K. D., Parkinson E. K., Harrison P. R., Profiling ear (Pubitemid 40220338)
2. Corry J., Peters L. J., Rischin D., Optimising the therapeutic ratio in head and neck cancer The Lancet Oncology 2010 11 3 287 291
3. Rosenthal D. I., Lewin J. S., Eisbruch A., Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer Journal of Clinical Oncology 2006 24 17 2636 2643 (Pubitemid 46622085)
4. Machtay M., Moughan J., Trotti A., Garden A. S., Weber R. S., Cooper J. S., Forastiere A., Ang K. K., Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis Journal of Clinical Oncology 2008 26 21 3582 3589
5. Bernier J., Bentzen S. M., Vermorken J. B., Molecular therapy in head and neck oncology Nature Reviews Clinical Oncology 2009 6 5 266 277
6. Kim J. W., Amin A. R.M.R., Shin D. M., Chemoprevention of head and neck cancer with green tea polyphenols Cancer Prevention Research 2010 3 8 900 909
7. Yang C. S., Wang X., Lu G., Picinich S. C., Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nature Reviews Cancer 2009 9 6 429 439
8. Yang C. S., Chen L., Lee M. J., Balentine D., Kuo M. C., Schantz S. P., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers Cancer Epidemiology Biomarkers and Prevention 1998 7 4 351 354 (Pubitemid 28354149)
9. Chow H. H. S., Cai Y., Alberts D. S., Hakim I., Dorr R., Shahi F., Crowell J. A., Yang C. S., Hara Y., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and Polyphenon E Cancer Epidemiology Biomarkers and Prevention 2001 10 1 53 58 (Pubitemid 32106044)
10. Tsao A. S., Liu D., Martin J., Tang XI. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao LI., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions Cancer Prevention Research 2009 2 11 931 941
11. Shimizu M., Fukutomi Y., Ninomiya M., Nagura K., Kato T., Araki H., Suganuma M., Fujiki H., Moriwaki H., Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study Cancer Epidemiology Biomarkers and Prevention 2008 17 11 3020 3025
12. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study Cancer Research 2006 66 2 1234 1240 (Pubitemid 43165995)
13. Grandis J. R., Melhem M. F., Barnes E. L., Tweardy D. J., Quantitative immunohistochemical analysis of transforming growth factor- and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck Cancer 1996 78 6 1284 1292 (Pubitemid 26303896)
14. Grandis J. R., Melhem M. F., Gooding W. E., Day R., Holst V. A., Wagener M. M., Drenning S. D., Tweardy D. J., Levels of TGF- and EGFR protein in head and neck squamous cell carcinoma and patient survival Journal of the National Cancer Institute 1998 90 11 824 832 (Pubitemid 28280548)
15. Kalyankrishna S., Grandis J. R., Epidermal growth factor receptor biology in head and neck cancer Journal of Clinical Oncology 2006 24 17 2666 2672 (Pubitemid 46622088)
16. Reuter C. W. M., Morgan M. A., Eckardt A., Targeting EGF-receptor- signalling in squamous cell carcinomas of the head and neck British Journal of Cancer 2007 96 3 408 416 (Pubitemid 46215210)
17. Masuda M., Wakasaki T., Suzui M., Toh S., Joe A. K., Weinstein I. B., Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? Current Cancer Drug Targets 2010 10 1 117 126
18. Mrhalova M., Plzak J., Betka J., Kodet R., Epidermal growth factor receptorits expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas Neoplasma 2005 52 4 338 343 (Pubitemid 41076203)
19. Benchekroun M. T., Saintigny P., Thomas S. M., El-Naggar A. K., Papadimitrakopoulou V., Ren H., Lang W., Fan Y.-H., Huang J., Feng L., Lee J. J., Kim E. S., Hong W. K., Johnson F. M., Grandis J. R., Mao L., Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer Cancer Prevention Research 2010 3 7 800 809
20. Zhang Q., Thomas S. M., Xi S., Smithgall T. E., Siegfried J. M., Kamens J., Gooding W. E., Grandis J. R., Src family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells Cancer Research 2004 64 17 6166 6173 (Pubitemid 39129418)
21. Willmore-Payne C., Holden J. A., Layfield L. J., Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck Modern Pathology 2006 19 5 634 640
22. Jong W. L., Young H. S., Su Y. K., Hyo K. N., Won S. P., Suk W. N., Min S. K., Dong IL. S., Youn S. L., Ja J. J., Jung Y. L., Nam J. Y., Sug H. L., Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck Clinical Cancer Research 2005 11 8 2879 2882 (Pubitemid 40525187)
23. Hama T., Yuza Y., Saito Y., O-Uchi J., Kondo S., Okabe M., Yamada H., Kato T., Moriyama H., Kurihara S., Urashima M., Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma Oncologist 2009 14 9 900 908
24. Sok J. C., Coppelli F. M., Thomas S. M., Lango M. N., Xi S., Hunt J. L., Freilino M. L., Graner M. W., Wikstrand C. J., Bigner D. D., Gooding W. E., Furnari F. B., Grandis J. R., Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting Clinical Cancer Research 2006 12 17 5064 5073 (Pubitemid 44453332)
25. Yang B., Chen J., Zhang X., Cao J., Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues Auris Nasus Larynx 2009 36 6 682 687
26. Sorkin A., Goh L. K., Endocytosis and intracellular trafficking of ErbBs Experimental cell research 2009 315 4 683 696
27. Dikic I., CIN85/CMS family of adaptor molecules FEBS Letters 2002 529 1 110 115 (Pubitemid 35283919)
28. Wakasaki T., Masuda M., Niiro H., Jabbarzadeh-Tabrizi S., Noda K., Taniyama T., Komune S., Akashi K., A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the Ras-ERK pathway Neoplasia 2010 12 10 789 796
29. Rotblat B., Yizhar O., Haklai R., Ashery U., Kloog Y., Ras and its signals diffuse through the cell on randomly moving nanoparticles Cancer Research 2006 66 4 1974 1981
30. Liang Y. U. C., Lin-shiau S. Y., Chen C. F., Lin J. K., Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells Journal of Cellular Biochemistry 1997 67 1 55 65
31. Masuda M., Suzui M., Weinstein I. B., Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines Clinical Cancer Research 2001 7 12 4220 4229 (Pubitemid 34044648)
32. Masuda M., Suzui M., Lim J. T. E., Weinstein I. B., Epigallocatechin-3- gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells Clinical Cancer Research 2003 9 9 3486 3491 (Pubitemid 37082748)
33. Masuda M., Suzui M., Lim J. T. E., Deguchi A., Soh J. W., Weinstein I. B., Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction Journal of Experimental Therapeutics and Oncology 2002 2 6 350 359 (Pubitemid 35265984)
34. Shimizu M., Deguchi A., Hara Y., Moriwaki H., Weinstein I. B., EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells Biochemical and Biophysical Research Communications 2005 334 3 947 953 (Pubitemid 41033211)
35. Shimizu M., Deguchi A., Joe A. K., Mckoy J. F., Moriwaki H., Weinstein I. B., EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells Journal of Experimental Therapeutics and Oncology 2005 5 1 69 78 (Pubitemid 41076992)
36. Shimizu M., Deguchi A., Lim J. T. E., Moriwaki H., Kopelovich L., Weinstein I. B., (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells Clinical Cancer Research 2005 11 7 2735 2746 (Pubitemid 40569476)
37. Shimizu M., Shirakami Y., Moriwaki H., Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG International Journal of Molecular Sciences 2008 9 6 1034 1049 (Pubitemid 351948839)
38. Shimizu M., Shirakami Y., Sakai H., Yasuda Y., Kubota M., Adachi S., Tsurumi H., Hara Y., Moriwaki H., (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells Chemico-Biological Interactions 2010 185 3 247 252
39. Le Roy C., Wrana J. L., Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling Nature Reviews Molecular Cell Biology 2005 6 2 112 126 (Pubitemid 40215807)
40. Patra S. K., Dissecting lipid raft facilitated cell signaling pathways in cancer Biochimica et Biophysica Acta 2008 1785 2 182 206
41. Lajoie P., Goetz J. G., Dennis J. W., Nabi I. R., Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane Journal of Cell Biology 2009 185 3 381 385
42. Lingwood D., Simons K., Lipid rafts as a membrane-organizing principle Science 2010 327 5961 46 50
43. Adachi S., Nagao T., Ingolfsson H. I., Maxfield F. R., Andersen O. S., Kopelovich L., Weinstein I. B., The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells Cancer Research 2007 67 13 6493 6501 (Pubitemid 47037535)
44. Adachi S., Nagao T., To S., Joe A. K., Shimizu M., Matsushima-Nishiwaki R., Kozawa O., Moriwaki H., Maxfield F. R., Weinstein I. B., (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells Carcinogenesis 2008 29 10 1986 1993
45. Adachi S., Shimizu M., Shirakami Y., Yamauchi J., Natsume H., Matsushima-Nishiwaki R., To S., Weinstein I. B., Moriwaki H., Kozawa O., (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells Carcinogenesis 2009 30 9 1544 1552
46. Tachibana H., Koga K., Fujimura Y., Yamada K., A receptor for green tea polyphenol EGCG Nature Structural and Molecular Biology 2004 11 4 380 381 (Pubitemid 38436804)
47. Umeda D., Yano S., Yamada K., Tachibana H., Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor Journal of Biological Chemistry 2008 283 6 3050 3058
48. Patra S. K., Rizzi F., Silva A., Rugina D. O., Bettuzzi S., Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts Journal of Physiology and Pharmacology 2008 59 supplement 9 217 235
49. Zhang X., Zhang H., Tighiouart M., Lee J. E., Shin H. J., Khuri F. R., Yang C. S., Chen Z., Shin D. M., Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor International Journal of Cancer 2008 123 5 1005 1014